Kawasaki, Japan

Hiroyuki Eda

This inventor holds 1 USPTO granted patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Eda. Retrieved from https://idiyas.com/inventor/hiroyuki-eda-9zky0ywn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Hiroyuki Eda

Introduction

Hiroyuki Eda is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on sulfonamide derivatives.

Latest Patents

Hiroyuki Eda holds a patent for a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds characterized by a specific chemical structure, which includes a sulfonamide group with a phenyl group or a heterocyclic group containing hetero atoms as substituents. These novel compounds exhibit excellent α4 integrin-inhibitory action and are accompanied by pharmaceutically acceptable salts.

Career Highlights

Eda is associated with Ea Pharma Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues through innovative chemical compounds.

Collaborations

Hiroyuki Eda collaborates with esteemed colleagues, including Hirokazu Ueno and Takashi Yamamoto. Their combined expertise enhances the research environment and fosters innovation within their projects.

Conclusion

Hiroyuki Eda's contributions to medicinal chemistry through his patented innovations highlight the importance of research in developing new therapeutic agents. His work exemplifies the impact of inventive thinking in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…